Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-03

Clinical Trial Update: Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effects of cannabidiol (CBD) on autophagy and inflammation gene activation in virologically controlled HIV-infected pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: Centre Hospitalier Régional d'Orléans | Conditions: HIV Seropositivity | Phase 2 | Status: COMPLETED